Results 71 to 80 of about 755 (138)

The Stability of Drugs Commonly Used in Intensive Care Units Co-Administered via Feeding Tube and Its Dependence on pH: An in vitro Study.

Pharmacology
Papiež A, Suk P, Baránková R, Hančlová P, Šrámek V, Odehnalová K.   +5 more
europepmc   +1 more source

Comparative Efficacy and Safety of Novel Antiplatelets and Standard Therapy in Patients With Coronary Artery Disease. [PDF]

Cureus
Gangavarapu RR, Mahmud SA, Manandhar A, Sabir G, Abdelhady HA, Oumar Abakar A, Nassar ST.   +6 more
europepmc   +1 more source

Optimal antiplatelet therapy in patients with acute coronary syndrome and chronic kidney disease: for the Jerusalem platelets thrombosis and intervention in cardiology (JUPITER-11) study group. [PDF]

BMC Nephrol
Nimrod P, David M, Louay T, Meir T, Amsalem I, Hitter R, Maller T, Levy N, Lupu L, Shmueli H, Bruoha S, Ovdat T, Glikson M, Asher E.   +13 more
europepmc   +1 more source

Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial. [PDF]

EuroIntervention
Paradies V, Van Mieghem NM, Oemrawsingh RM, Richardt G, Esposito G, Campo G, Burzotta F, Canova P, Linke A, Porto I, Trabattoni D, Teeuwen K, Adriaenssens T, Kala P, Stankovic G, Vliet RV, Giacoppo D, Daemen J, Smits PC.   +18 more
europepmc   +1 more source

Prasugrel Intermediate Metabolite Modulates Platelet Inhibition by Negatively Interfering With an Active Metabolite: An Ex Vivo, In Vitro, and In Silico Study. [PDF]

Arterioscler Thromb Vasc Biol
Minuz P, Giorgetti A, Meneguzzi A, Taus F, Ribeiro RP, Baldessari F, Gargiulo G, Gragnano F, Landi A, Castelli M, Gottardo R, Bortolotti F, Verlato G, Fava C, Cattaneo M, Tagliaro F, Valgimigli M.   +16 more
europepmc   +1 more source

Laparoscopic Cholecystectomy in a Patient with Low-Lying Costal Arch due to Ankylosing Spondylitis: A Case Report. [PDF]

Surg Case Rep
Fukami T, Minato H, Kosuga T, Arita T.
europepmc   +1 more source

Exploring the relationship of platelet aggregation function with efficacy and safety outcomes following the administration of prasugrel and clopidogrel in patients with thrombotic stroke: a post hoc analysis of PRASTRO pooled studies. [PDF]

J Thromb Thrombolysis
Kimura K, Kamouchi M, Matsumaru Y, Kimura T, Katsuro R, Hosokawa J, Kitazono T.   +6 more
europepmc   +1 more source

Ticagrelor is Associated with Increased Rosuvastatin Blood Concentrations in Patients who have had a Myocardial Infarction. [PDF]

Clin Pharmacokinet
Dermota T, Jug B, Trontelj J, Božič Mijovski M.   +3 more
europepmc   +1 more source

Pharmacodynamic effects of early aspirin withdrawal after percutaneous coronary intervention in patients with atrial fibrillation treated with ticagrelor or prasugrel. [PDF]

Platelets
Sammut MA, Rahman MEF, Bridge C, Hanson J, Judge H, Lynch B, Maz E, McMellon H, Middle J, Williamson G, Parker WAE, Lee J, Storey RF.   +12 more
europepmc   +1 more source

Risk of major adverse cardiovascular events in CYP2C19 LoF genotype guided clopidogrel against alternative antiplatelets for CAD patients undergoing PCI: Meta-analysis. [PDF]

Clin Transl Sci
Biswas M, Murad MA, Ershadian M, Kali MSK, Sukasem C.   +4 more
europepmc   +1 more source